What is the role of microbial biotechnology and genetic engineering in medicine?

被引:10
作者
Santos-Beneit, Fernando [1 ,2 ,3 ]
机构
[1] Inst Sustainable Proc, Valladolid, Spain
[2] Univ Valladolid, Sch Ind Engn, Dept Chem Engn & Environm Technol, Valladolid, Spain
[3] Inst Sustainable Proc, Dr Mergelina S-N, Valladolid 47011, Spain
来源
MICROBIOLOGYOPEN | 2024年 / 13卷 / 02期
关键词
antibiotics; biotechnology; cancer; genetic engineering; medicine; microbiology; STREPTOMYCES-COELICOLOR; POLYKETIDE SYNTHASE; CONJUGATE VACCINE; ESCHERICHIA-COLI; RNA INTERFERENCE; THERAPEUTIC-USES; ORAL DELIVERY; PHO REGULON; CROSS-TALK; CELL;
D O I
10.1002/mbo3.1406
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Microbial products are essential for developing various therapeutic agents, including antibiotics, anticancer drugs, vaccines, and therapeutic enzymes. Genetic engineering techniques, functional genomics, and synthetic biology unlock previously uncharacterized natural products. This review highlights major advances in microbial biotechnology, focusing on gene-based technologies for medical applications. Microbial biotechnology, the technological application of microorganisms, has been instrumental in producing significant natural bioactive products. These include antibiotics, antifungals, anticancer drugs, antiparasitics, antivirals, immunosuppressants, toxoid vaccines, and therapeutic enzymes. Certain microbial components have proven invaluable in the creation of genetic tools, such as CRISPR-Cas systems and thermostable DNA polymerase enzymes. These tools are essential for the development of genetic engineering strategies. Genetic engineering, as a discipline, plays a crucial role in the rational and precise advancement of microbial biotechnology. Consequently, these two conceptual themes-microbial biotechnology and genetic engineering-exhibit a positive interplay. This review presents major advancements in microbial biotechnology, with a particular emphasis on gene-based technologies within the medical field. image
引用
收藏
页数:31
相关论文
共 251 条
  • [1] Selective targeting of point-mutated KRAS through artificial microRNAs
    Acunzo, Mario
    Romano, Giulia
    Nigita, Giovanni
    Veneziano, Dario
    Fattore, Luigi
    Lagana, Alessandro
    Zanesi, Nicola
    Fadda, Paolo
    Fassan, Matteo
    Rizzotto, Lara
    Kladney, Raleigh
    Coppola, Vincenzo
    Croce, Carlo M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (21) : E4203 - E4212
  • [2] Oral delivery of RNAi for cancer therapy
    Afrin, Humayra
    Geetha Bai, Renu
    Kumar, Raj
    Ahmad, Sheikh Shafin
    Agarwal, Sandeep K.
    Nurunnabi, Md
    [J]. CANCER AND METASTASIS REVIEWS, 2023, 42 (03) : 699 - 724
  • [3] Antimicrobial therapeutics isolated from algal source: retrospect and prospect
    Afzal, Shadma
    Yadav, Alok Kumar
    Poonia, Anuj Kumar
    Choure, Kamlesh
    Yadav, Ajar Nath
    Pandey, Ashutosh
    [J]. BIOLOGIA, 2023, 78 (02) : 291 - 305
  • [4] Chlorotoxin modified morusin-PLGA nanoparticles for targeted glioblastoma therapy
    Agarwal, Srishti
    Mohamed, M. Sheikh
    Mizuki, Toru
    Maekawa, Toru
    Kumar, D. Sakthi
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2019, 7 (39) : 5896 - 5919
  • [5] Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective
    Aggarwal, Varun
    Bala, Ekta
    Kumar, Pawan
    Raizada, Pankaj
    Singh, Pardeep
    Verma, Praveen Kumar
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (17) : 1664 - 1698
  • [6] Recent advances in microencapsulation of drugs for veterinary applications
    Ahmad, Salah Uddin
    Li, Bing
    Sun, Jichao
    Arbab, Safia
    Dong, Zhen
    Cheng, Fusheng
    Zhou, Xuzheng
    Mahfuz, Shad
    Zhang, Jiyu
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2021, 44 (03) : 298 - 312
  • [7] Phase 1 study of MEDI3902, an investigational anti-Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults
    Ali, S. O.
    Yu, X. Q.
    Robbie, G. J.
    Wu, Y.
    Shoemaker, K.
    Yu, L.
    DiGiandomenico, A.
    Keller, A. E.
    Anude, C.
    Hernandez-Illas, M.
    Bellamy, T.
    Falloon, J.
    Dubovsky, F.
    Jafri, H. S.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (05) : 629.e1 - 629.e6
  • [8] RNA interference: Promising approach for breast cancer diagnosis and treatment
    Allahyari, Elham
    Velaei, Kobra
    Sanaat, Zohreh
    Jalilzadeh, Nazila
    Mehdizadeh, Amir
    Rahmati, Mohammad
    [J]. CELL BIOLOGY INTERNATIONAL, 2023, 47 (05) : 833 - 847
  • [9] History of antimicrobial drug discovery: Major classes and health impact
    Aminov, Rustam
    [J]. BIOCHEMICAL PHARMACOLOGY, 2017, 133 : 4 - 19
  • [10] The Search for Antibacterial Inhibitors Targeting Cell Division Protein FtsZ at Its Nucleotide and Allosteric Binding Sites
    Andreu, Jose M.
    Huecas, Sonia
    Araujo-Bazan, Lidia
    Vazquez-Villa, Henar
    Martin-Fontecha, Mar
    [J]. BIOMEDICINES, 2022, 10 (08)